257 Aromatic aminoacid monoxygenases, catalytic and oligomerization domains
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Benzenoids | 3 | 0.7 | 4.16× | not tested | |
| Organoheterocyclic compounds | 6 | 1.5 | 3.95× | not tested | |
| Organic nitrogen compounds | 1 | 0.3 | 3.18× | not tested | |
| Organic acids and derivatives | 4 | 1.5 | 2.62× | not tested | |
| Homogeneous metal compounds | 10 | 4.8 | 2.07× | not tested | |
| Homogeneous non-metal compounds | 3 | 2.1 | 1.41× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04400 | HBI | 7,8-dihydrobiopterin | 10 |
| DB00360 | H4B | Sapropterin | 9 |
| DB00988 | LDP | Dopamine | 9 |
| DB00120 | PHE | Phenylalanine | 5 |
| DB15458 | NLE | Norleucine | 3 |
| DB03673 | TIH | beta-2-Thienyl-L-alanine | 2 |
| DB12095 | — | — | 2 |
| DB00135 | — | Tyrosine | 1 |
| DB00150 | TRP | Tryptophan | 1 |
| DB00368 | LNR | Norepinephrine | 1 |
| DB00765 | — | — | 1 |
| DB01235 | DAH | Levodopa | 1 |
| DB02562 | H2B | Quinonoid 7,8-Tetrahydrobiopterin | 1 |
| DB03552 | — | — | 1 |
| DB04419 | — | — | 1 |
| DB06262 | — | — | 1 |
| DB18478 | 6Z4 | Rodatristat | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FEmetal | FE (III) ION | 92 |
| LDP | L-DOPAMINE | 13 |
| COmetal | COBALT (II) ION | 10 |
| HBI | 7,8-DIHYDROBIOPTERIN | 9 |
| H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 7 |
| CL | CHLORIDE ION | 6 |
| PIN | PIPERAZINE-N,N'-BIS(2-ETHANESULFONIC ACID) | 6 |
| FE2metal | FE (II) ION | 5 |
| PHE | PHENYLALANINE | 4 |
| ZNmetal | ZINC ION | 4 |
| NLE | NORLEUCINE | 3 |
| 6H5 | 4-[(N-{[2-(3-methoxyphenoxy)-6-(piperidin-1-yl)phenyl]methyl}carbamimidoyl)carbamoyl]-L-phenylalanine | 2 |
| A1IT9 | Telotristat | 2 |
| JCR | 8-(1~{H}-benzimidazol-2-ylmethyl)-3-ethyl-7-(phenylmethyl)purine-2,6-dione | 2 |
| TIH | BETA(2-THIENYL)ALANINE | 2 |
| 3QI | 5,6-DIMETHYL-3-(4-METHYL-2-PYRIDINYL)-2-THIOXO-2,3-DIHYDROTHIENO[2,3- D]PYRIMIDIN-4(1H)-ONE | 1 |
| 6Z4 | (3~{S})-8-[2-azanyl-6-[(1~{R})-1-(4-chloranyl-2-phenyl-phenyl)-2,2,2-tris(fluoranyl)ethoxy]pyrimidin-4-yl]-2,8-diazaspiro[4.5]decane-3-carboxylic acid | 1 |
| 7H5 | (3S)-8-(2-amino-6-{(1R)-1-[5-chloro-3'-(methylsulfonyl)[1,1'-biphenyl]-2-yl]-2,2,2-trifluoroethoxy}pyrimidin-4-yl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid | 1 |
| CCN | ACETONITRILE | 1 |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | 1 |